Pacific Biosciences Of California, Inc.

VANGUARD GROUP INC PACB

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

17,037,314

Value ($000)

31,860

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	31,860	0.0%	17,037,314	12/31/2025
2025 Q3	11/7/2025	20,966	0.0%	16,379,972	9/30/2025
2025 Q2	8/11/2025	19,861	0.0%	16,017,175	6/30/2025
2025 Q1	5/9/2025	19,191	0.0%	16,263,464	3/31/2025
2024 Q4	2/11/2025	27,865	0.0%	15,226,858	12/31/2024
2024 Q3	11/13/2024	29,993	0.0%	17,642,804	9/30/2024
2024 Q2	8/13/2024	35,619	0.0%	25,998,943	6/30/2024
2024 Q1	5/10/2024	99,774	0.0%	26,606,485	3/31/2024
2023 Q4	3/11/2024	262,806	0.0%	26,789,552	12/31/2023
2023 Q3	12/18/2023	194,344	0.0%	23,274,760	9/30/2023
2023 Q2	8/14/2023	307,586	0.0%	23,126,767	6/30/2023
2023 Q1	7/14/2023	257,952	0.0%	22,275,690	3/31/2023
2022 Q4	2/10/2023	165,883	0.0%	20,279,035	12/31/2022
2022 Q3	11/14/2022	114,138	0.0%	19,662,066	9/30/2022
2022 Q2	8/12/2022	93,887	0.0%	21,241,318	6/30/2022
2022 Q1	5/13/2022	181,499	0.0%	19,945,092	3/31/2022
2021 Q4	2/14/2022	406,230	0.0%	19,854,876	12/31/2021
2021 Q3	11/12/2021	459,814	0.0%	17,996,649	9/30/2021
2021 Q2	8/13/2021	636,346	0.0%	18,196,904	6/30/2021
2021 Q1	5/14/2021	591,788	0.0%	17,766,083	3/31/2021
2020 Q4	2/12/2021	371,468	0.0%	14,320,299	12/31/2020
2020 Q3	11/16/2020	102,352	0.0%	10,369,976	9/30/2020
2020 Q2	8/14/2020	27,526	0.0%	7,978,476	6/30/2020
2020 Q1	5/15/2020	22,848	0.0%	7,467,151	3/31/2020
2019 Q4	2/14/2020	40,485	0.0%	7,876,485	12/31/2019
2014 Q2	8/11/2014	9,001	0.0%	1,456,433	6/30/2014
2014 Q1	5/13/2014	7,249	0.0%	1,354,866	3/31/2014
2013 Q4	2/12/2014	5,242	0.0%	1,002,385	12/31/2013